Roques BP - Search Results

1

Comparative conformational analysis of CCK-B agonist Boc-Trp-Phg-Asp-(1-Nal)-NH2 and CCK1-B antagonist Boc-Trp-Phg-Asp-(1-Nal)-N(Me)2 using 1HNMR spectroscopy and restrained molecular dynamics.

Goudreau N, Weng JH, Roques BP. Goudreau N, et al. Among authors: roques bp. Arch Pharm (Weinheim). 1996 Apr;329(4):197-204. doi: 10.1002/ardp.19963290405. Arch Pharm (Weinheim). 1996. PMID: 8669984

2

Conformational analysis of CCK-B agonists using 1H-NMR and restrained molecular dynamics: comparison of biologically active Boc-Trp-(N-Me) Nle-Asp-Phe-NH2 and inactive Boc-Trp-(N-Me)Phe-Asp-Phe-NH2.

Goudreau N, Weng JH, Roques BP. Goudreau N, et al. Among authors: roques bp. Biopolymers. 1994 Feb;34(2):155-69. doi: 10.1002/bip.360340202. Biopolymers. 1994. PMID: 8142585

3

CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives.

Corringer PJ, Weng JH, Ducos B, Durieux C, Boudeau P, Bohme A, Roques BP. Corringer PJ, et al. Among authors: roques bp. J Med Chem. 1993 Jan 8;36(1):166-72. doi: 10.1021/jm00053a022. J Med Chem. 1993. PMID: 8421283

4

Role of N- and C-terminal substituents on the CCK-B agonist-antagonist pharmacological profile of Boc-Trp-Phg-Asp-Nal-NH2 derivatives.

Weng JH, Blommaert AG, Moizo L, Bado A, Ducos B, Böhme A, Garbay C, Roques BP. Weng JH, et al. Among authors: roques bp. Bioorg Med Chem. 1996 Apr;4(4):563-73. doi: 10.1016/0968-0896(96)00050-8. Bioorg Med Chem. 1996. PMID: 8735845

5

Novel CCK-B receptor agonists: diketopiperazine analogues derived for CCK4 bioactive conformation.

Weng JH, Bado A, Garbay C, Roques BP. Weng JH, et al. Among authors: roques bp. Regul Pept. 1996 Aug 27;65(1):3-9. doi: 10.1016/0167-0115(96)00065-1. Regul Pept. 1996. PMID: 8876029

6

Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.

Blommaert AG, Dhôtel H, Ducos B, Durieux C, Goudreau N, Bado A, Garbay C, Roques BP. Blommaert AG, et al. Among authors: roques bp. J Med Chem. 1997 Feb 28;40(5):647-58. doi: 10.1021/jm9603072. J Med Chem. 1997. PMID: 9057851

7

Mutation of Asp100 in the second transmembrane domain of the cholecystokinin B receptor increases antagonist binding and reduces signal transduction.

Jagerschmidt A, Guillaume N, Goudreau N, Maigret B, Roques BP. Jagerschmidt A, et al. Among authors: roques bp. Mol Pharmacol. 1995 Nov;48(5):783-9. Mol Pharmacol. 1995. PMID: 7476907

8

NMR structure of the N-terminal SH3 domain of GRB2 and its complex with a proline-rich peptide from Sos.

Goudreau N, Cornille F, Duchesne M, Parker F, Tocqué B, Garbay C, Roques BP. Goudreau N, et al. Among authors: roques bp. Nat Struct Biol. 1994 Dec;1(12):898-907. doi: 10.1038/nsb1294-898. Nat Struct Biol. 1994. PMID: 7773779

9

Solid-phase synthesis, conformational analysis and in vitro cleavage of synthetic human synaptobrevin II 1-93 by tetanus toxin L chain.

Cornille F, Goudreau N, Ficheux D, Niemann H, Roques BP. Cornille F, et al. Among authors: roques bp. Eur J Biochem. 1994 May 15;222(1):173-81. doi: 10.1111/j.1432-1033.1994.tb18855.x. Eur J Biochem. 1994. PMID: 8200342 Free article.

10

Cholecystokinin peptidomimetics as selective CCK-B antagonists: design, synthesis, and in vitro and in vivo biochemical properties.

Blommaert AG, Weng JH, Dorville A, McCort I, Ducos B, Durieux C, Roques BP. Blommaert AG, et al. Among authors: roques bp. J Med Chem. 1993 Oct 1;36(20):2868-77. doi: 10.1021/jm00072a005. J Med Chem. 1993. PMID: 8411002

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

714 results

Search Page

Filters